Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Christians

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Artificial Organs|September 1, 1995
Reconstruction of liver tissue in vitro: geometry of characteristic flat bed, hollow fiber, and spouted bed bioreactors with reference to the in vivo liverA Bader, E Knop, N Frühauf, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 22, 1999
Small intestinal metabolism of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor lovastatin and comparison with pravastatinW Jacobsen, G Kirchner, K Hallensleben, et al.
Transplantation|October 2, 2001
Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeysB Hausen, J Klupp, U Christians, et al.
Clinical Chemistry|October 1, 1992
Specific and sensitive measurement of FK506 and its metabolites in blood and urine of liver-graft recipientsU Christians, F Braun, M Schmidt, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Ciclosporin metabolite pattern in blood and urine of kidney graft patients in relation to liver functionJ S Bleck, H J Schlitt, U Christians, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1996
Tacrolimus (FK 506) biotransformation in primary rat hepatocytes depends on extracellular matrix geometryA Bader, E Knop, K H Böker, et al.
Transplantation|October 3, 2000
Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primatesT S Ikonen, J F Gummert, M Hayase, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Ciclosporin metabolite pattern in blood and urine of liver graft recipients. II. Influence of cholestasis and rejectionU Christians, K Kohlhaw, J Budniak, et al.
British Journal of Clinical Pharmacology|June 1, 1996
Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipientsJ S Bleck, C Thiesemann, V Kliem, et al.
Transplantation|October 27, 1996
A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipientsM Winkler, G Haller, K Oldhafer, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Artificial Organs|September 1, 1995
Reconstruction of liver tissue in vitro: geometry of characteristic flat bed, hollow fiber, and spouted bed bioreactors with reference to the in vivo liverA Bader, E Knop, N Frühauf, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 22, 1999
Small intestinal metabolism of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor lovastatin and comparison with pravastatinW Jacobsen, G Kirchner, K Hallensleben, et al.
Transplantation|October 2, 2001
Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeysB Hausen, J Klupp, U Christians, et al.
Clinical Chemistry|October 1, 1992
Specific and sensitive measurement of FK506 and its metabolites in blood and urine of liver-graft recipientsU Christians, F Braun, M Schmidt, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Ciclosporin metabolite pattern in blood and urine of kidney graft patients in relation to liver functionJ S Bleck, H J Schlitt, U Christians, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1996
Tacrolimus (FK 506) biotransformation in primary rat hepatocytes depends on extracellular matrix geometryA Bader, E Knop, K H Böker, et al.
Transplantation|October 3, 2000
Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primatesT S Ikonen, J F Gummert, M Hayase, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Ciclosporin metabolite pattern in blood and urine of liver graft recipients. II. Influence of cholestasis and rejectionU Christians, K Kohlhaw, J Budniak, et al.
British Journal of Clinical Pharmacology|June 1, 1996
Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipientsJ S Bleck, C Thiesemann, V Kliem, et al.
Transplantation|October 27, 1996
A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipientsM Winkler, G Haller, K Oldhafer, et al.
Pageof 9